Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting.
Eric SenbelSonia TropéHélène Herman-DemarsElena ZinovievaAgnès CourbeyrettePierre ClersonYann FardiniRené-Marc FlipoPublished in: Patient preference and adherence (2021)
Overall, change from oral to SC route improved adherence to MTX, RA control and quality of life independently of change in MTX dose.